Euler Manenti (@emanenti) 's Twitter Profile
Euler Manenti

@emanenti

MD PhD FACC
INSTITUTO DE MEDICINA CARDIOVASCULAR CORA CENTER CLINICAL TRAILIST
#diabetocardiology #CardioOncology#thrombocardiology

ID: 36465807

calendar_today29-04-2009 20:14:55

814 Tweet

583 Takipçi

3,3K Takip Edilen

The Lancet (@thelancet) 's Twitter Profile Photo

Heterozygous familial hypercholesterolemia is a common genetic condition characterised by high LDL cholesterol levels from a young age. A new Review discusses the contemporary knowledge of familial hypercholesterolaemia and its unmet clinical needs: hubs.li/Q03QmHhS0

Heterozygous familial hypercholesterolemia is a common genetic condition characterised by high LDL cholesterol levels from a young age.

A new Review discusses the contemporary knowledge of familial hypercholesterolaemia and its unmet clinical needs: hubs.li/Q03QmHhS0
Ramon Bataller (@rabataller) 's Twitter Profile Photo

New insights on assessing LIVER FIBROSIS with NON-INVASIVE TESTS, just released by NEJM: - Key techniques & thresholds. - Practical algorithms & actionable steps. shorturl.at/amz1p

New insights on assessing LIVER FIBROSIS with NON-INVASIVE TESTS, just released by <a href="/NEJM/">NEJM</a>:

- Key techniques &amp; thresholds.
- Practical algorithms &amp; actionable steps.
shorturl.at/amz1p
AJPC (@ajpcardio) 's Twitter Profile Photo

🧬 New research alert: Comparison of PREVENT Score versus the Pooled Cohort Equation for estimating ASCVD risk in patients with Rheumatoid Arthritis. Explore the full study 👉 ow.ly/zrxH50XjT5h #Cardiology #RA #ASCVD #RiskPrediction #PreventiveCardiology

🧬 New research alert: Comparison of PREVENT Score versus the Pooled Cohort Equation for estimating ASCVD risk in patients with Rheumatoid Arthritis. Explore the full study 👉 ow.ly/zrxH50XjT5h

#Cardiology #RA #ASCVD #RiskPrediction #PreventiveCardiology
Dr Gary McGowan (@drgarymcgowan) 's Twitter Profile Photo

LDL-ApoB discordance ⚖️ ➡️ most pronounced in metabolically unhealthy obesity ➡️ metabolic dysfunction, more than obesity, drives increased apoB–LDL-C discordance lipidjournal.com/article/S1933-…

Eric Topol (@erictopol) 's Twitter Profile Photo

GLP-1 drugs have intrinsic potent anti-inflammatory action beyond their metabolic beneficial impact on glucose regulation and weight loss Daniel J Drucker Journal of Clinical Investigation jci.org/articles/view/…

GLP-1 drugs have intrinsic potent anti-inflammatory action beyond their metabolic beneficial impact on glucose regulation and weight loss <a href="/DanielJDrucker/">Daniel J Drucker</a> <a href="/jclinicalinvest/">Journal of Clinical Investigation</a> 
jci.org/articles/view/…
Marcos Gamboa (@markinho_gc) 's Twitter Profile Photo

🔰Patobiología de la prediabetes. 🤓Esta revisión analiza la transición desde la regulación normal de la glucosa, pasando por la disglucemia hasta llegar a prediabetes. 👍Evalúa factores de riesgo, complicaciones y estrategias de tratamiento. doi.org/10.2337/dbi25-… 𝘋𝘳𝘢. 𝒜𝒞 ⚕🪬

🔰Patobiología de la prediabetes.

🤓Esta revisión analiza la transición desde la regulación normal de la glucosa, pasando por la disglucemia hasta llegar a prediabetes.
👍Evalúa factores de riesgo, complicaciones y estrategias de tratamiento.
doi.org/10.2337/dbi25-…
<a href="/anymzcs/">𝘋𝘳𝘢. 𝒜𝒞 ⚕🪬</a>
Marcos Gamboa (@markinho_gc) 's Twitter Profile Photo

En este metanálisis con 58 816 pacientes usuarios de iSGLT2, agrupados en grupos con DM y sin DM, RAC ≥ 200 mg o < 200 mg/g. 🎯Se evidencio beneficios absolutos en eficacia renal, menor hospitalización y mortalidad independiente de tener o no DM, o de tener albuminuria mayor o

En este metanálisis con 58 816 pacientes usuarios de iSGLT2, agrupados en grupos con DM y sin DM, RAC ≥ 200 mg o &lt; 200 mg/g. 
🎯Se evidencio beneficios absolutos en eficacia renal, menor hospitalización y mortalidad independiente de tener o no DM, o de tener albuminuria mayor o
Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Combo triple agonist for FGF21 R/ Glucagon R/ GLP1 R lowers triglycerides by 69% v placebo among individuals with severe hypertriglyceridemia in a ph2 trial of N=79 #AHA25

Combo triple agonist for FGF21 R/ Glucagon R/ GLP1 R lowers triglycerides by 69% v placebo among individuals with severe hypertriglyceridemia in a ph2 trial of N=79 #AHA25
Dr. Filippo Cademartiri (@fcademartiri) 's Twitter Profile Photo

🚀 Calcium Score & CCTA: Key Highlights from the 2025 AHA Scientific Statement (DOI: 10.1161/CIR.0000000000001394) Non-obstructive CAD in Chest Pain Patients 🧊 1. CAC = Atherosclerotic Burden, Not Just a Number CAC is one of the strongest predictors of future ASCVD risk—better

🚀 Calcium Score &amp; CCTA: Key Highlights from the 2025 AHA Scientific Statement (DOI: 10.1161/CIR.0000000000001394)

Non-obstructive CAD in Chest Pain Patients

🧊 1. CAC = Atherosclerotic Burden, Not Just a Number
CAC is one of the strongest predictors of future ASCVD risk—better
Pradeep Natarajan (@pnatarajanmd) 's Twitter Profile Photo

Exciting to see Merck's enlicitide (oral PCSK9 inhibitor) continue to show very high LDL-C-lowering efficacy (~ -60%) now in multiple trials jamanetwork.com/journals/jama/… JAMA AHA Science #AHA25 Enlicitide is an important pharmacologic success that has key innovations to

Eric Topol (@erictopol) 's Twitter Profile Photo

There's a big shift in cardiology to the high-risk, non-obstructed, inflamed artery and reducing heart attacks erictopol.substack.com/p/the-big-shif…

There's a big shift in cardiology to the high-risk, non-obstructed, inflamed artery and reducing heart attacks
erictopol.substack.com/p/the-big-shif…
Larronde Esteban (@estebandl) 's Twitter Profile Photo

Ecografía para detectar resistencia a la insulina Es momento de abandonar la glucemia como marcador de enfermedad Y la IA llegó para ayudarnos a llegar 10 años antes Ecografía muscular y diagnóstico de resistencia a insulina

Ecografía para detectar resistencia a la insulina

Es momento de abandonar la glucemia como marcador de enfermedad

Y la IA llegó para ayudarnos a llegar 10 años antes

Ecografía muscular y diagnóstico de resistencia a insulina
AJPC (@ajpcardio) 's Twitter Profile Photo

New paper: Risk matters for ASCVD — but vascular resilience may decide the outcome. Insightful work by Michael D. Shapiro and Khurram Nasir on why not all high-risk patients experience events. ow.ly/6cfj50XxfnQ #CardioResearch #VascularResilience #PreventiveCardiology @aspcardio

New paper: Risk matters for ASCVD — but vascular resilience may decide the outcome. Insightful work by <a href="/DrMichaelShapir/">Michael D. Shapiro</a> and <a href="/khurramn1/">Khurram Nasir</a> on why not all high-risk patients experience events.
ow.ly/6cfj50XxfnQ
#CardioResearch #VascularResilience #PreventiveCardiology @aspcardio